Dr Reddy’s receives Establishment Inspection Report for New York API facility

The USFDA has classified the outcome of the inspection as ‘Voluntary Action Indicated’ (VAI) and has officially closed the inspection. Shares of Dr Reddy’s Laboratories Ltd ended at ₹1,259.50, up by ₹1.40, or 0.11%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *